Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-([hydroxy[1-([N-[(4-nitrobenzyl)sulfonyl]-D-alanyl]amino)ethyl]phosphoryl]methyl)pentanedioic acid | 1 mM, 13% residual activity | Staphylococcus aureus | |
2-[[(1-[[(2E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]ethyl)(hydroxy)phosphoryl]methyl]pentanedioic acid | 1 mM, 52% residual activity | Staphylococcus aureus | |
2-[[(1-[[(benzyloxy)carbonyl]amino]ethyl)(hydroxy)phosphoryl]methyl]pentanedioic acid | 1 mM, 35% residual activity | Staphylococcus aureus | |
2-[[hydroxy(1-[[(2E)-3-(3-hydroxyphenyl)prop-2-enoyl]amino]ethyl)phosphoryl]methyl]pentanedioic acid | 1 mM, 21% residual activity | Staphylococcus aureus | |
2-[[hydroxy(1-[[(2E)-3-phenylprop-2-enoyl]amino]ethyl)phosphoryl]methyl]pentanedioic acid | 1 mM, 50% residual activity | Staphylococcus aureus | |
2-[[hydroxy(1-[[(3-nitrobenzyl)sulfonyl]amino]ethyl)phosphoryl]methyl]pentanedioic acid | 1 mM, 52% residual activity | Staphylococcus aureus | |
2-[[hydroxy(1-[[(3-nitrophenyl)sulfonyl]amino]ethyl)phosphoryl]methyl]pentanedioic acid | 1 mM, 39% residual activity | Staphylococcus aureus | |
2-[[hydroxy(1-[[(4-nitrobenzyl)sulfonyl]amino]ethyl)phosphoryl]methyl]pentanedioic acid | 1 mM, 44% residual activity | Staphylococcus aureus | |
2-[[hydroxy(2-methyl-1-[[(3-nitrobenzyl)sulfonyl]-amino]butyl)phosphoryl]methyl]pentanedioic acid | 1 mM, 71% residual activity | Staphylococcus aureus | |
2-[[hydroxy(2-methyl-1-[[(4-nitrobenzyl)sulfonyl]-amino]butyl)phosphoryl]methyl] pentanedioic acid | 1 mM, 54% residual activity | Staphylococcus aureus | |
2-[[hydroxy(2-methyl-1-[[(4-nitrobenzyl)sulfonyl]amino]propyl)phosphoryl]methyl] pentanedioic acid | 1 mM, 29% residual activity | Staphylococcus aureus | |
2-[[[1-[(1,3-benzodioxol-5-ylacetyl)amino]ethyl](hydroxy)phosphoryl]methyl]pentanedioic acid | 1 mM, 12% residual activity; 1 mM, 42% residual activity; 1 mM, 60% residual activity | Staphylococcus aureus | |
3-[(1-[[(benzyloxy)carbonyl]amino]ethyl)(hydroxy)phosphoryl]propanoic acid | 1 mM, 50% residual activity | Staphylococcus aureus | |
3-[hydroxy[1-([N-[(4-nitrobenzyl)sulfonyl]-D-alanyl]amino)ethyl]phosphoryl]propanoic acid | 1 mM, 46% residual activity | Staphylococcus aureus | |
3-[[1-[(1,3-benzodioxol-5-ylacetyl)amino]ethyl](hydroxy)phosphoryl]propanoic acid | 1 mM, 35% residual activity | Staphylococcus aureus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Staphylococcus aureus | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + UDP-N-acetylmuramoyl-L-Ala-D-Glu + L-Lys | - |
Staphylococcus aureus | ADP + phosphate + UDP-N-acetylmuramoyl-L-Ala-D-Glu-L-Lys | - |
? |
Synonyms | Comment | Organism |
---|---|---|
MurE | - |
Staphylococcus aureus |
UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: L-lysine ligase | - |
Staphylococcus aureus |